the drug used will be off markets in all 50 states. at least during the period where the injunction is in force. dr. krystin brandi says patients will be able to get a medication abortion even if theg is banned by using the other drug and a combination it s a little bit less effective. maybe side effects were people needing additional care. meg influences the outcome may undermine the fda approval process, setting damaging precedent. meg oliver, cbs news, new jersey. norah: here in washington the crackdown on tiktok continues, the drug gave government agencies 30 days to remove the video sharing app from all federal devices and computer systems. the office of management and budget says the move is aimed at protecting u.s. data, officials suspect china is using the app to spy on americans. the ban does not impact more than 100 million americans and teens who use tiktok on
in europe have been growing healthy for decades, so i can t imagine a situation where there would be some drastic change from what we re doing here. i think here in america, it just has to do with the fda approval process and why that hasn t really been done before because frankly, we ve never needed it until this period. so, i m hopeful that once it comes in, it s going to be safe and effective and those babies will get that nutrition that they need. dr. blake bergeron, really helpful information. thank you for being with us. thank you so much, my pleasure. so, right now, in pennsylvania, it is still too close to call as officials continue to count the votes in the republican senate primary. we re going to take you there live for an update next. [bacon sizzles] [bacon sizzles] [electronic music plays]
and there is still such a shortage of testing. this is a failure by the trump administration and the biden administration. as somebody who pursues your own tests as much as you can get them for arkansans, somebody who works with the federal government both trump and biden, what is the problem? why are there not enough tests? well, there are plenty of pcr tests. so you can go anywhere and get a test. it s just not rapid. and so the shortage is one particular area of tests. right. that kind. pardon? that is the kind i m talking about. the home test. there is a shortage there. why? we had to wait for the fda approval process. they had to step up the manufacturing. could have the defense production act been utilized more quickly? i don t know the answer to that question. i m dealing in the reality of what we face at this particular
you could use to basically, you know, mitigate the infection. so that was missing in the fda approval process. they did not have that concept of frequency. nor they had a concept of a test that is not just for diagnosis, like we all know medical professionals need, but also population, something that is called monitoring and that the fda does not regulate and still doesn t have a template or any kind of mandate to companies to do. i m sorry, dr. hilton, understanding that this test is not as sensitive, it still could have been very helpful in picking up what would later become superspreader events. and we are still grappling with this question of testing. i want you to take a listen to president biden. mr. president, what s your message to americans who are
The FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the drug's approval process has stirred controversy.